MAIA
MAIA
AMEX · Biotechnology

Maia Biotechnology Inc

$1.97
+0.06 (+3.14%)
As of Feb 8, 2:15 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 31.19M 31.61M 26.89M
Net Income 2.24M 2.16M 1.99M
EPS
Profit Margin 7.2% 6.8% 7.4%
Rev Growth -3.9% +21.8% -6.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 8.28M 8.26M 8.25M
Total Equity 26.05M 30.65M 28.39M
D/E Ratio 0.32 0.27 0.29
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 3.54M 3.42M 2.98M
Free Cash Flow 1.72M 2.00M 2.13M